Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of 2-Mercaptoethanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.45 |
| ▸ | PDE4A known ✓ | P27815 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Mercaptoethanesulfonic Acid SCHEMBL7993 | 1.00 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL26112497 | 0.97 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL21333894 | 0.97 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL10412576 | 0.93 | KDM4E (0.88) | KDM4EMAPTALOX15ENPEPALDH1A1 | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL3271658 | 0.93 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL8048597 | 0.93 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL14988940 | 0.93 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL6316228 | 0.93 | — | — | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL8048601 | 0.93 | KDM4E (0.88) | KDM4EMAPTALOX15ENPEPALDH1A1 | |
| 2-Mercaptoethanesulfonic Acid SCHEMBL10413265 | 0.93 | KDM4E (0.88) | KDM4EMAPTALOX15ENPEPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019024784-A1 | FATTY ACID CONJUGATED NANOPARTICLES AND USES THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2019-02-07 | — | — | WO | claimed |
| US-20190029970-A1 | FATTY ACID CONJUGATED NANOPARTICLES AND USES THEREOF | THE CHINESE UNIVERSITY OF HONG KONG (CN) | 2019-01-31 | — | — | US | claimed |
| CN-102015739-A | Novel compounds and methods for treatment | GILEAD SCIENCES INC | 2011-04-13 | — | — | CN | claimed |
| WO-2007149103-A2 | VASCULAR TISSUE ENHANCEMENT AND SELECTIVE DESTRUCTION OF CANCEROUS CELLULAR TISSUE | KAISER DANIEL E (US) | 2007-12-27 | — | — | WO | claimed |
| EP-4444323-A1 | ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF | Cila Therapeutic Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| US-20240307333-A1 | ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF | Cila Therapeutics Inc. (US) | 2024-09-19 | — | — | US | disclosed |
| WO-2023180353-A1 | COMBINATION TREATMENT OF AN ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODY AND CHEMOTHERAPY | F. HOFFMANN-LA ROCHE AG (CH) | 2023-09-28 | — | — | WO | disclosed |
| CN-116529360-A | Methods and compositions for stimulating γδ T cells | 弗罗里达中央大学研究基金会 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023107996-A1 | ANTI-VIRAL THERAPEUTIC AGENTS AND USES THEREOF | CILA THERAPEUTIC INC. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-10928405-B2 | Devices and methods for determining and/or isolating cells such as circulating cancer or fetal cells | ANALIZA, INC. (US) | 2021-02-23 | — | — | US | disclosed |
| EP-3675838-A1 | LYMPHATIC SYSTEM-DIRECTING LIPID PRODRUGS | Puretecch LYT, Inc. (US) | 2020-07-08 | — | — | EP | disclosed |
| EP-3080341-B1 | METHODS FOR DETERMINING AND/OR ISOLATING CELLS SUCH AS CIRCULATING CANCER OR FETAL CELLS | ANALIZA INC (US) | 2020-02-12 | — | — | EP | disclosed |
| CN-102015739-A | Novel compounds and methods for treatment | GILEAD SCIENCES INC | 2011-04-13 | — | — | CN | disclosed |
| CN-101903384-A | As [1H-pyrazolo [3,4-B] the pyridin-4-yl]-phenyl of protein kinase C theta inhibitors or-pyridine-2-radical derivative | VERTEX PHARMA | 2010-12-01 | — | — | CN | disclosed |
| CN-101801959-A | Aminopyrimidines useful as kinase inhibitors | VERTEX PHARMA | 2010-08-11 | — | — | CN | disclosed |
| CN-101679378-A | Thiazoles and pyrazoles as kinase inhibitors | VERTEX PHARMA | 2010-03-24 | — | — | CN | disclosed |
| CN-101679387-A | Aminopyrimidines useful as kinase inhibitors | VERTEX PHARMA | 2010-03-24 | — | — | CN | disclosed |
| CN-101663276-A | 2-aminopyridine derivatives useful as kinase inhibitors | VERTEX PHARMA | 2010-03-03 | — | — | CN | disclosed |
| CN-101500613-A | A novel lactic acid formulation of MK-0457 useful for the treatment of cancer | MERCK & CO INC (US) | 2009-08-05 | — | — | CN | disclosed |
| US-20050058622-A1 | Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimens | IMMUNEX CORPORATION | 2005-03-17 | — | — | US | disclosed |